THERAPEUTIC AGENT The invention concerns a novel pharmaceutical agent which comprises a new crystalline form of a substituted quinoline derivative (defined herein) which is a potent antagonist of angiotensin AII and of use in treating conditions such as hypertension, congestive heart disease or hyperaldosteronism. A process for the production of the novel crystalline form and pharmaceutical compositions containing it are also included.
申请公布号
CA2060825(A1)
申请公布日期
1992.08.09
申请号
CA19922060825
申请日期
1992.02.07
申请人
IMPERIAL CHEMICAL INDUSTRIES PLC
发明人
BARKER, ALAN C.;PEARCE, ROBERT J.;ROBERTS, DAVID A.;RUSSELL, SIMON T.